• OPEN AN ACCOUNT
Indian Indices
Sensex
83,674.92 -558.72
( -0.66%)
Global Indices
Nasdaq
50,155.23 -53.92
(-0.11%)
Dow Jones
6,964.65 1.84
(0.03%)
Hang Seng
57,686.98 36.44
(0.06%)
Nikkei 225
10,491.19 137.35
(1.33%)
Forex
USD-INR
90.60 -0.06
(-0.06%)
EUR-INR
107.84 0.20
(0.18%)
GBP-INR
123.81 0.16
(0.13%)
JPY-INR
0.58 0.00
(0.79%)

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
539524
INE600L01024
139.7140778
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LALPATHLAB
45.05
24172.32
EPS(TTM)
Face Value()
Div & Yield %
32.02
10
0.83
 

MCX soars past Rs 10,000 mark amid sustained rally
Nov 26,2025
The stock touched a fresh lifetime high of Rs 10,250 intraday. MCX has gained 5.82% over the past three sessions, rising 13.46% in one month and 33.05% in three months.

The stock has delivered a spectacular run in 2025, soaring 132.15% in just eight months from its 52-week low of Rs 4,408 hit on 11 March.

The rally has been amplified by a surge in precious metals and other commodities traded on the platform, driving heightened investor interest. Adding to the momentum, a domestic brokerage recently initiated coverage with a target price of Rs 12,500, implying nearly 22.08% upside from current levels. A foreign brokerage has also lifted its target price to Rs 12,000 from Rs 10,000 while retaining its 'Buy' rating.

MCX is India's largest commodity derivatives exchange with around 98% market share in commodity futures. It offers trading in a diverse range of commodities, spanning multiple segments including bullion, energy, metals and agri commodities, as well as sectoral commodity indices.

It reported 29% rise in consolidated net profit to Rs 197.47 crore on a 31% increase in revenue to Rs 374.23 crore in Q2 FY26 over Q2 FY25.